| First Author | Authier H | Year | 2008 |
| Journal | Mol Immunol | Volume | 45 |
| Issue | 1 | Pages | 235-43 |
| PubMed ID | 17568676 | Mgi Jnum | J:124281 |
| Mgi Id | MGI:3721206 | Doi | 10.1016/j.molimm.2007.04.007 |
| Citation | Authier H, et al. (2008) Interleukin-13 primes iNO synthase expression induced by LPS in mouse peritoneal macrophages. Mol Immunol 45(1):235-243 |
| abstractText | Th2 cytokines such as interleukin-13 (IL-13) have both, stimulatory and inhibitory effects on effector functions of macrophages. Reactive nitrogen species are classicaly induced in Th1 cytokines and/or lipopolysaccharides (LPS) activated macrophages and this response is inhibited by IL-13. In contrast, IL-13 primes macrophages to produce NO in response to LPS when IL-13 treatment happens prior to LPS exposure. This mechanism occurs through a complex signalling pathway, which involves the scavenger receptor CD36, the LPS receptor CD14 and the nuclear receptor PPARgamma. The enhancement of NO production is the consequence of iNOS induction at mRNA and protein levels. The increase of the NO production induced by LPS in IL-13 pre-treated macrophages is found to potentiate the inhibition of Toxoplasma gondii intracellular replication. These results reveal a novel IL-13 signalling pathway that primes the antimicrobial activity of macrophages induced by LPS caused by overexpression of the iNOS-NO axis. |
